The principal objective of the WIPO Re:Search public-private consortium is to make a range of knowledge-based assets, such as pharmaceutical and vaccine compounds, discovery technologies, clinical data and know-how, available under license to the global R&D community focused on Neglected Tropical Diseases (NTDs), malaria, and tuberculosis (TB). As elaborated in the Guiding Principles, any products developed for these diseases under a WIPO Re:Search license are meant to be made available on a royalty-free basis in all Least Developed Countries. Access terms for other, non-Least Developed, developing countries are subject to agreement between the licensor and licensee.
The WIPO Re:Search database is accessible to anyone wishing to become familiar with the technologies available for licensing. The initial listing available at the launch of WIPO Re:Search (October 2011) will grow over time into a larger and more comprehensive catalogue relevant technologies, IP and know-how over time
Providers to the database submit summary information relevant to, inter alia: hits, leads, lead series, pre-clinical candidates, clinical candidates, enabling technologies, intellectual property, formulation, diagnostic tools, vaccine, new biological entities, knowhow, or other services for the purpose of facilitating R&D for NTDs, malaria, and TB. This goal is accomplished, in the first instance, by allowing free and open access to the database, with the understanding that the posting of information on the database does not imply a license.
If an individual or other entity is interested in learning more about a particular item in the database, they should contact either the Partnership Hub administrator or the organization submitting the information. If an eventual license is agreed, the license will be provided on terms consistent with the Guiding Principles.
As WIPO Re:Search develops over time, WIPO and the Partnership Hub Administrator will collect and analyze feedback in order to ensure that the consortium’s operations, in particular the database and related services, are useful to the global health research community focused on NTDs, malaria and TB.